The Campylobacter ELISA is an enzyme-linked immunosorbent assay for the qualitative identification of Campylobacter jejuni and Campylobacter coli antigens in human stool samples and in cultures. For Research Use Only. Not for use in diagnostic procedures.
The Campylobacter ELISA employs monoclonal antibodies in a sandwich-type method. The well surface of the microwell plate is coated with monoclonal antibodies to Campylobacter antigens.
A pipette is used to place a suspension of the stool sample to be examined, as well as control samples into the wells of the microplate together with biotinylated anti-Campylobacter antibodies (Conjugate 1) for incubation at room temperature (20 – 25 °C). After a wash step, streptavidin poly-peroxidase conjugate (Conjugate 2) is added, and it is incubated again at room temperature (20 – 25 °C). With the presence of Campylobacter antigens in a sample, immobilized antibodies, antigens, and conjugated antibodies form a sandwich complex. Another wash step removes the unattached streptavidin poly-peroxidase conjugate. After adding the substrate, the attached enzyme changes the color of the previously colorless solution in the wells of the microplate to blue if the test is positive. Addition of a stop reagent changes the color from blue to yellow. The signal observed is proportional to the concentration of the Campylobacter antigen that is found in the sample.
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
In a head-to-head comparison of FDA-cleared assays and a novel ALPCO method, investigators observed wide variability in specificity and false-positive rates across platforms, raising important questions about standardization and clinical interpretation.
July 22, 2025 – Salem, NH – NuvinkaDx, a leading innovator in diagnostic solutions, today announced two significant product and regulatory milestones from its operating companies, GeneProof and ALPCO.
Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.
Complement System Solutions for Drug Development and Clinical Research Datasheet
The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.
Melatonin Products for Sleep Disorder-Related Research Datasheet
The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.